powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1053738039
Chelsey Baldwin
MD
Endocrinology
Washington,
DC
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 090001
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
633
Beneficiaries
—
Total drug cost
$268K
Distinct drugs
18
Brand share
52.3%
Top prescribed drugs
Levothyroxine Sodium
125 claims
Tirzepatide
107 claims
Semaglutide
37 claims
Empagliflozin
34 claims
Metformin Hcl
32 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$538
Payment records
20
By payment type
Food and Beverage
$538
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
367
Unique beneficiaries
—
Total services
539
Distinct HCPCS
11
Medicare payment
$39K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 32 Endocrinology providers in DC — top quintile (cohort median 727).